BioInvent International AB (publ) Profit Margin

The latest profit margin for BINV.ST is -1528.11% as of June 2026. That compares with -114.81% in the prior-year period — down 1231.0% year over year. That is below the Healthcare sector average of 9.71%. Investors often review this figure alongside BioInvent International AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, BINV.ST's profit margin moved from -114.81% to -1528.11% — a 1231.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioInvent International AB (publ)'s valuation or profitability profile.

Against Healthcare companies, BINV.ST currently prints -1528.11% for profit margin, while the sector average sits near 9.71%. That is roughly 15844.0% below the sector mean. Large gaps often invite a closer look at BioInvent International AB (publ)'s growth, margins, and balance sheet.

Profit Margin shows how effectively BioInvent International AB (publ) converts resources into returns. At -1528.11%, BINV.ST may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -114.81% in the prior-year period — down 1231.0% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BINV.ST's profit margin (-1528.11%), review year-over-year change from -114.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.